Mary Van Beusekom | News Writer | CIDRAP NewsMay 25, 2020The data show the antiviral drug cut recovery time from 15 to 11 days.
Study: Remdesivir benefits some COVID-19 patients
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- US respiratory virus activity continues to tail off
- Global health groups propose new terminology for pathogens that spread through the air
- COVID vaccination in kids protects against serious outcomes, but it wanes over time, new data show
- Severe COVID in older adults may be due to greater viral load, weaker immune response